| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive review on polyelectrolyte complexes
|
Meka, Venkata S.
|
|
2017
|
22 |
11 |
p. 1697-1706
|
artikel
|
| 2 |
Aged macular degeneration: current therapeutics for management and promising new drug candidates
|
Abd, Afrah Jalil
|
|
2017
|
22 |
11 |
p. 1671-1679
|
artikel
|
| 3 |
Contents page 1
|
|
|
2017
|
22 |
11 |
p. i
|
artikel
|
| 4 |
Contents page 2
|
|
|
2017
|
22 |
11 |
p. ii
|
artikel
|
| 5 |
Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline
|
Menshykau, Denis
|
|
2017
|
22 |
11 |
p. 1598-1603
|
artikel
|
| 6 |
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
|
Zhang, Lu
|
|
2017
|
22 |
11 |
p. 1680-1685
|
artikel
|
| 7 |
2016 in review: FDA approvals of new molecular entities
|
Griesenauer, Rebekah H.
|
|
2017
|
22 |
11 |
p. 1593-1597
|
artikel
|
| 8 |
Mechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery
|
Meghani, Nilesh M.
|
|
2017
|
22 |
11 |
p. 1604-1619
|
artikel
|
| 9 |
Microfluidic technologies for anticancer drug studies
|
Valente, Karolina P.
|
|
2017
|
22 |
11 |
p. 1654-1670
|
artikel
|
| 10 |
Molecular epigenetic targets for liver diseases: current challenges and future prospects
|
Zeidler, Robert
|
|
2017
|
22 |
11 |
p. 1620-1636
|
artikel
|
| 11 |
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
|
Hansen, Henrik H.
|
|
2017
|
22 |
11 |
p. 1707-1718
|
artikel
|
| 12 |
Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
|
Madariaga-Mazón, Abraham
|
|
2017
|
22 |
11 |
p. 1719-1729
|
artikel
|
| 13 |
Myotonic dystrophy: candidate small molecule therapeutics
|
Konieczny, Piotr
|
|
2017
|
22 |
11 |
p. 1740-1748
|
artikel
|
| 14 |
Stem cells in cardiovascular diseases: turning bad days into good ones
|
Oliveira, Maira Souza de
|
|
2017
|
22 |
11 |
p. 1730-1739
|
artikel
|
| 15 |
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
|
Antonioli, Luca
|
|
2017
|
22 |
11 |
p. 1686-1696
|
artikel
|
| 16 |
The Warburg effect and glucose-derived cancer theranostics
|
Tekade, Rakesh K.
|
|
2017
|
22 |
11 |
p. 1637-1653
|
artikel
|
Tijdschrift beschrijving